Abstract
The density and subtype pattern of β-adrenoceptors in equine tracheal epithelium, tracheal smooth muscle and heart from 6–9 horses were investigated by radioligand binding studies using the non-selective β-adrenoceptor antagonist 125I-cyanopindolol (ICYP). The specific binding of ICYP was 341±162 fmol/mg protein (mean±SD) for epithelium, 42±13 fmol/mg for smooth muscle and 124±39 and 101±19 fmol/mg for the cardiac atrium and ventricle, respectively. The Kd value of ICYP was 6.7–10.2 pmol/L.
In competition studies, different concentrations of either the β2-selective drug ICI 118551 or the β1-selective CGP 20712A competed with 25 pmol/L ICYP for the binding sites. The competition curves for tracheal smooth muscle and epithelium were monophasic with an approximate Kd value for ICI 118551 of 1 nmol/L and for CGP 20712A of 10 000 nmol/L. This corresponds to known Kd values for these substances binding to β2-adrenoceptors. β2-Adrenoceptors were also found in the heart, most pronounced in the atrium, where the density was 29%±6% (mean±SD) of the total receptor density. CGP 20712A and ICI 118551 bound to the dominating binding site of β1-adrenoceptors in the heart with Kd values of approximately 1 nmol/L and 100 nmol/L, respectively.
Similar content being viewed by others
REFERENCES
Agrawal, D.K., Schugel, J.W. and Townley, R.G., 1987. Comparison of beta adrenoceptors in bovine airway epithelium and smooth muscle cells. Biochemical and Biophysical Research Communication, 148, 178–183
Barnes, P.J., Basbaum, C.B., Nadel, J.A. and Roberts, J.M., 1982. Localization of b–adrenoceptors in mammalian lung by light microscopic autoradiography. Nature, 299, 444–447
Barnes, P.J., Nadel, J.A., Skoogh, B.–E. and Roberts, J.M., 1983. Characterization of beta adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses. Journal of Pharmacology and Experimental Therapeutics, 225, 456–461
Bjornerheim, R., Golf, S. and Hansson, V., 1989. Apparent lack of beta 2 adrenergic receptors in porcine myocardium. Cardiovascular Research, 23, 577–583
Carstairs, J.R., Nimmo, A.J. and Barnes, P.J., 1985. Autoradiographic visualization of beta–adrenoceptor subtypes in human lung. American Review of Respiratory Diseases, 132, 541–547
Cheng, V.C. and Prusoff, W.H., 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzyme reaction. Biochemical Pharmacology, 22, 3099–3108
De Lean, A., Hancock, A.M. and Lefkowitz, R.J., 1982. Validation and statistical analysis of radioligand binding data for mixtures of pharmacological subtypes. Molecular Pharmacology, 21, 5–16
Derksen, F.J., 1994. Anecdotes and clinical trials: the story of clenbuterol. Equine Veterinary Journal, 26, 256–258
Dixon, P.M., 1992. Respiratory mucociliary clearance in the horse in health and disease, and its pharmaceutical modification. The Veterinary Record, 131, 229–235
Dooley, D.J., Bittiger, H. and Reymann, N.C., 1986. CGP 20712 A: a useful tool for quantitating b1– and b2–adrenoceptors. European Journal of Pharmacology, 130, 137–139
Engel, G., Hoyer, D., Berthold, R. and Wagner, H., 1981. (+/–) [125Iodo]cyanopindolol, a new ligand for beta–adrenoceptors: identification and quantitation of subclasses of beta–adrenoceptors in guinea pigs. Naunyn Schmiedebergs Archives of Pharmacology, 317, 277–285
Erichsen, D.F., Aviad, A.D., Schultz, R.H. and Kennedy, T.J., 1994. Clinical e¤cacy and safety of clenbuterol HCl when administered to e¡ect in horses with chronic obstructive pulmonary disease (COPD). Equine Veterinary Journal, 26, 331–336
Golf, S., Lovstad, R. and Hansson, V., 1985. Beta–adrenoceptor density and relative number of beta– adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocardium. Cardiovascular Research, 19, 636–641
Ingvast Larsson, C., 1991. Relaxant effects of theophylline and clenbuterol on tracheal smooth muscle from horse and rat in vitro. Journal of Veterinary Pharmacology and Therapeutics, 14, 310–316
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275
Madden, K.S., Sanders, V.M. and Felten, D.L., 1995. Catecholamine in£uence and sympathetic neural modulation of immune responsiveness. Annual Review of Pharmacology and Toxicology, 35, 417–448
O'Donnell, S.R. and Wanstall, J.C., 1980. Evidence that ICI 118, 551 is a potent, highly beta 2–selective adrenoceptor antagonist and can be used to characterize beta–adrenoceptor populations in tissues. Life Science, 27, 671–677
Rang, H.P., Dale,M.M. and Ritter, J.M., 1995. Pharmacology, 3rd edn, (Laurence Hunter, New York), 33, 159–162, 289, 317, 358–359
Sasse, H.L. and Hajer, R., 1978. NAB 365, a beta 2–receptor sympathomimetic agent: clinical experience in horses with lung disease. Journal of Veterinary Pharmacology and Therapeutics, 1, 241–244
Skoogh, B.–E., Löthwall, J., Löfdahl, C.–G. and Svedmyr, N., 1989. Classification of b–adrenoceptors in ferret tracheal smooth muscle by pharmacological responses. Pulmonary Pharmacology, 1, 173–177
Törneke, K., Ingvast Larsson, C. and Appelgren, L.–E., 1997. Relaxation of equine tracheal muscle in vitro by di¡erent adrenoceptor drugs. Journal of Veterinary Pharmacology and Therapeutics, 20, 216–219
Törneke, K., Ingvast Larsson, C. and Appelgren, L.-E., 1998. A comparison between clenbuterol, salbutamol and terbutaline in relation to receptor binding and in vitro relaxation of equine tracheal muscle. Journal of Veterinary Pharmacology and Therapeutics, 21, 388–392
Turgut, K. and Sasse, H.H.L., 1989. Influence of clenbuterol on mucociliary transport in healthy horses with chronic obstructive pulmonary disease. The Veterinary Record, 125, 526–530
van Koppen, C.J., Hermanussen, M.W., Verrijp, K.N., de Miranda, J.F.R., Beld, A.J., Lammers, J.–W.J. and van Ginneken, C.A.M., 1987. b–Adrenoceptors in human tracheal smooth muscle: characteristics of binding and relaxation. Life Science, 40, 2561–2570
Waldeck, B., Jeppsson, A.B. and Widmark, E., 1986. Partial agonism and functional selectivity: a study on beta–adrenoceptor mediated e¡ects in tracheal, cardiac and skeletal muscle. Acta Pharmacologica et Toxicologica Copenhagen, 58, 209–218
Zhou, H.–H., Silberstein, D.J., Koshakji, R.P. and Wood, A.J.J., 1989. Interindividual di¡erences in b– receptor density contribute to variability in response to b–adrenoceptor antagonists. Clinical Pharma– cology and Therapeutics, 45, 587–592
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Törneke, K. β-Adrenoceptors in Equine Trachea and Heart. Vet Res Commun 23, 41–51 (1999). https://doi.org/10.1023/A:1006154905374
Issue Date:
DOI: https://doi.org/10.1023/A:1006154905374